Orli Tori
Private Equity Investor chez TriVentures Management Ltd.
Profil
Orli Tori is currently a Partner at TriVentures Management Ltd.
Previously, Mr. Tori held positions as Chairman at Israel Tech Transfer Organization, Director at Alcobra Ltd.
and Arcturus Therapeutics Ltd., and Senior Vice President at Neopharm Ltd.
Mr. Tori received undergraduate and graduate degrees from Tel-Aviv University and an MBA from Harvard Business School.
Postes actifs de Orli Tori
| Sociétés | Poste | Début |
|---|---|---|
TriVentures Management Ltd.
 TriVentures Management Ltd. Investment ManagersFinance Triventures Management Ltd. (Triventures) is a venture capital firm founded in 2007 by Michal Geva, Dr. Peter Fitzgerald and Dr. Martin Leon. The firm is headquartered in Herzliya, Israel. | Private Equity Investor | 01/01/2020 |
Anciens postes connus de Orli Tori
| Sociétés | Poste | Fin |
|---|---|---|
| Israel Tech Transfer Organization | Président | - |
Arcturus Therapeutics Ltd.
 Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | - |
Neopharm Ltd. (Israel)
 Neopharm Ltd. (Israel) Miscellaneous Commercial ServicesCommercial Services Neopharm Ltd. is a pharmaceutical and biotechnology company based in Petach Tikva, Israel. and has subsidiaries in Israel. Neopharm Ltd. engages in research and development of pharmaceutical and biotechnology products. The Israeli company was founded in 1941 by Leopold Goldschmidt. David Fuhrer has been the CEO of the private company since 1980. | Corporate Officer/Principal | - |
Alcobra Ltd.
 Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of central nervous system disorders and cognitive dysfunctions. Its portfolio includes Metadoxine Extended Release to treat Attention Deficit Hyperactivity Disorder and Fragile X Syndrome. The company was founded by Ehud Moshe Gilboa and Dalia Megiddo on February 7, 2008 and is headquartered in Tel Aviv, Israel. | Directeur/Membre du Conseil | - |
Formation de Orli Tori
| Tel-Aviv University | Graduate Degree |
| Harvard Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Alcobra Ltd.
Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of central nervous system disorders and cognitive dysfunctions. Its portfolio includes Metadoxine Extended Release to treat Attention Deficit Hyperactivity Disorder and Fragile X Syndrome. The company was founded by Ehud Moshe Gilboa and Dalia Megiddo on February 7, 2008 and is headquartered in Tel Aviv, Israel. | Health Technology |
TriVentures Management Ltd.
TriVentures Management Ltd. Investment ManagersFinance Triventures Management Ltd. (Triventures) is a venture capital firm founded in 2007 by Michal Geva, Dr. Peter Fitzgerald and Dr. Martin Leon. The firm is headquartered in Herzliya, Israel. | Finance |
Neopharm Ltd. (Israel)
Neopharm Ltd. (Israel) Miscellaneous Commercial ServicesCommercial Services Neopharm Ltd. is a pharmaceutical and biotechnology company based in Petach Tikva, Israel. and has subsidiaries in Israel. Neopharm Ltd. engages in research and development of pharmaceutical and biotechnology products. The Israeli company was founded in 1941 by Leopold Goldschmidt. David Fuhrer has been the CEO of the private company since 1980. | Commercial Services |
| Israel Tech Transfer Organization | |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA. | Health Technology |
